A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain
An Open-label, Single-dose, Pharmacokinetic Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Orthodontic Pain
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Listed as NCT05844995, this PHASE1 trial focuses on Orthodontic Pain and remains completed. Sponsored by Johnson & Johnson Consumer Inc. (J&JCI), it has been updated 11 times since 2023, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Feb 2024 — Apr 2024 [monthly]
Recruiting PHASE1
-
Jan 2024 — Feb 2024 [monthly]
Recruiting PHASE1
▶ Show 6 earlier versions
-
Dec 2023 — Jan 2024 [monthly]
Recruiting PHASE1
-
Nov 2023 — Dec 2023 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Sep 2023 — Nov 2023 [monthly]
Not Yet Recruiting PHASE1
-
Aug 2023 — Sep 2023 [monthly]
Not Yet Recruiting PHASE1
-
Jul 2023 — Aug 2023 [monthly]
Not Yet Recruiting PHASE1
-
Jun 2023 — Jul 2023 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Johnson & Johnson Consumer Inc. (J&JCI)
For direct contact, visit the study record on ClinicalTrials.gov .